Literature DB >> 6299469

Characterization and partial purification of neuroblastoma growth inhibitory factor from the culture medium of glioblasts.

Y Sakazaki, T Kato, H Kato, J Ito, R Tanaka, N Naganawa, T Kato, A Masaoka, H Tsunooka.   

Abstract

Neuroblastoma growth inhibitory factor (NGIF) exists in the conditioned medium of normal rat glioblasts. When neuroblastoma cells (Neuro2a, NS-20Y, and N1E-115) were cultured in the presence of the factor, the cell growth rates and DNA synthesis were markedly inhibited and the morphological differentiation including neural process formation was induced. However, the factor neither altered the growth rate nor the morphology of non-neuronal cells such as glial cell lines (C6 and 354A) or fibroblast (3T3). The molecular weight of the factor was estimated to be 75,000 Mr by gel filtration with Bio-Gel P-200, and the isoelectric point was 5.8. The factor was devoid of esteropeptidase activity, and susceptible to protease and thermal treatment. The growth inhibitory action of the factor was unrelated to the intracellular contents of cyclic AMP and GMP. The ability of NGIF to suppress preferentially the neural growth suggests its regulatory role in normal brain development.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6299469     DOI: 10.1016/0006-8993(83)90476-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Glial conditioned media inhibit the proliferation of cultured rat cerebellar astrocytes.

Authors:  F Aloisi; C Agresti; G Levi
Journal:  Neurochem Res       Date:  1987-02       Impact factor: 3.996

2.  Inhibition of tumor cell growth by protein factors derived from the developing mouse brain.

Authors:  N Miwa; S Mizuno
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

3.  Enhancement of both intracellular uptake and antitumor action of cisplatinum on human neuroblastoma cells by encapsulation in liposomes.

Authors:  Y Kamio; H Kato; T Kishikawa; T Toda; S Sasaki; J Ito; T Kato; R Tanaka
Journal:  Jpn J Cancer Res       Date:  1989-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.